Got 90 seconds? Then listen to executive director and CEO of Volpara Health Technologies Ralph Highnam tell us more about the company and its upcoming news flow.

Volpara provides breast imaging analytics and analysis products to improve clinical decision making and the early detection of breast cancer.

The company has seen an impressive 72% rise in its share price in 2019, climbing from $1.09 to $1.88.

We gave executive director and CEO Ralph Highnam 90 seconds to tell us more about the company and its significant upcoming newsflow.

Have a good idea for our next 90 Seconds With segment? Email us at tv@stockhead.com.au.